Insider Transactions in Q1 2023 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,007
-0.39%
|
$827,754
$822.95 P/Share
|
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
183
-0.07%
|
$150,792
$824.12 P/Share
|
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,793
-4.02%
|
$2,304,225
$825.17 P/Share
|
|
Mar 27
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,800
+5.1%
|
$1,444,000
$380.45 P/Share
|
|
Mar 24
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-49.86%
|
$1,014,320
$818.0 P/Share
|
|
Mar 24
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+33.27%
|
$471,200
$380.95 P/Share
|
|
Mar 23
2023
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Indirect |
3,656
-0.23%
|
$2,939,424
$804.29 P/Share
|
|
Mar 23
2023
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Direct |
25,000
-7.41%
|
-
|
|
Mar 23
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
2,192
-10.64%
|
$1,766,752
$806.47 P/Share
|
|
Mar 23
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
6,742
-19.71%
|
$5,400,342
$801.59 P/Share
|
|
Mar 23
2023
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+22.62%
|
$2,700,000
$270.43 P/Share
|
|
Mar 10
2023
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Bona fide gift
|
Indirect |
1,006
-100.0%
|
-
|
|
Mar 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-5.02%
|
$834,900
$759.89 P/Share
|
|
Mar 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.78%
|
$409,200
$372.46 P/Share
|
|
Mar 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$76,200
$762.44 P/Share
|
|
Feb 22
2023
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
29,005
-7.91%
|
$21,753,750
$750.16 P/Share
|
|
Feb 22
2023
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
42,500
+10.39%
|
$11,475,000
$270.43 P/Share
|
|
Feb 12
2023
|
Marion Mc Court EVP Commercial |
SELL
Payment of exercise price or tax liability
|
Direct |
1,276
-5.78%
|
$958,276
$751.78 P/Share
|
|
Feb 07
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.33%
|
$769,000
$769.04 P/Share
|
|
Feb 07
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.15%
|
$372,000
$372.46 P/Share
|
|
Feb 06
2023
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Indirect |
13,189
-6.17%
|
$10,551,200
$800.08 P/Share
|
|
Feb 06
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-7.51%
|
$398,500
$797.0 P/Share
|
|
Feb 06
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,071
-71.12%
|
$2,450,658
$798.0 P/Share
|
|
Feb 06
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,071
+41.56%
|
$1,596,920
$520.01 P/Share
|
|
Feb 06
2023
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
3,613
-36.64%
|
$2,890,400
$800.0 P/Share
|
|
Feb 06
2023
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,613
+26.82%
|
$1,741,466
$482.68 P/Share
|
|
Feb 06
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
752
-0.17%
|
$594,080
$790.24 P/Share
|
|
Feb 03
2023
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,021
-45.02%
|
$795,359
$779.0 P/Share
|
|
Feb 03
2023
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,021
+31.04%
|
$387,980
$380.95 P/Share
|
|
Feb 03
2023
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,286
-13.93%
|
$2,543,364
$774.29 P/Share
|
|
Feb 03
2023
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+17.49%
|
$1,350,000
$270.43 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,248
-6.4%
|
$1,739,952
$774.29 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+7.87%
|
$1,143,000
$381.92 P/Share
|
|
Feb 03
2023
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
739
-2.25%
|
$564,596
$764.5 P/Share
|
|
Feb 01
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$75,700
$757.46 P/Share
|
|
Feb 01
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-4.75%
|
$827,200
$752.19 P/Share
|
|
Feb 01
2023
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+4.53%
|
$409,200
$372.46 P/Share
|
|
Jan 27
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1
-0.08%
|
$747
$747.0 P/Share
|
|
Jan 27
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1
+0.08%
|
$520
$520.01 P/Share
|
|
Jan 06
2023
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
3,070
-71.11%
|
$2,293,290
$747.14 P/Share
|
|
Jan 06
2023
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,070
+41.56%
|
$1,596,400
$520.01 P/Share
|
|
Jan 04
2023
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
291
-0.23%
|
-
|
|
Jan 03
2023
|
Arthur F Ryan Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+0.85%
|
-
|
|
Jan 03
2023
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$72,700
$727.0 P/Share
|
|
Jan 03
2023
|
George L Sing Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+0.63%
|
-
|
|
Jan 03
2023
|
Christine A Poon Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+7.49%
|
-
|
|
Jan 03
2023
|
Joseph L Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+2.57%
|
-
|
|
Jan 03
2023
|
Michael S Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
165
+11.69%
|
-
|
|
Jan 03
2023
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-4.75%
|
$793,100
$721.86 P/Share
|